Purchase Order 75N95A21P00066

The National Institute of Neurological Disorders and Stroke awarded a purchase order to Miltenyi Biotec, Inc. valued at $24,990.50 on April 6, 2021. Work is performed in Auburn, California. The order procures specialized biotechnology equipment, reagents, or services supporting cell separation, analysis, and processing technologies for biomedical research and cell therapy development. The purchase order is firm fixed price with no set-aside designation and carries an ultimate completion date...

The National Institute of Nursing Research awarded a purchase order to Miltenyi Biotec, Inc. valued at $13,612.17 on March 25, 2020, with an ultimate completion date of January 14, 2021. The order is a firm fixed price, commercial acquisition with no set-aside designation. Place of performance is Auburn, California. The purchase order procures specialized biotechnology equipment, reagents, and consumables for cell separation, analysis, and processing technologies that support biomedical research...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. on January 6, 2021, for a GentleMACS Octo Dissociator, with a ceiling value of $24,984.62 under firm fixed price, no set-aside terms. Performance is located in Auburn, California. The order completed on February 5, 2021. The underlying solicitation was posted December 30, 2020, with a due date of January 5, 2021.</p>

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for $24,980.62 on July 27, 2020, for scientific equipment with an ultimate completion date of August 31, 2020. No set-aside was used. Performance occurs in Auburn, California. The order procures specialized biotechnology equipment and reagents for cell separation, analysis, and processing technologies that support biomedical research and cell therapy development. Pricing is firm fixed price.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Miltenyi Biotec, Inc. for $4,884.00 on August 24, 2018. The order, with no set-aside designation, carries a firm fixed price and was completed by August 23, 2019. Performance took place in Auburn, California. The purchase order procured specialized biotechnology equipment, reagents, or consumables supporting the NIH Clinical Center's biomedical research and clinical operations.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $59,710 purchase order to Miltenyi Biotec, Inc. to deliver two GentleMACS Octo Dissociator units with heaters. The place of performance will be in Auburn, California, and the period of performance is from September 10, 2023 through December 30, 2023. This firm fixed price contract supports NIH/NIAID research efforts through the procurement of specialized...

The NIH Clinical Center awarded a $61,285 firm fixed-price purchase order to Miltenyi Biotec, Inc. for a preventative maintenance package, with performance in Bethesda, Maryland and an ultimate completion date of November 21, 2026. This award carries no set-aside designation, reflecting Miltenyi Biotec's status as a specialized sole-source supplier of proprietary biotechnology equipment and consumables. Miltenyi Biotec, headquartered in Auburn, California, is a foreign-owned manufacturer...

The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), awarded a $59,894.00 firm fixed-price purchase order to Miltenyi Biotec, Inc. to provide a LightSpeed Mode hardware and software upgrade package for the agency's existing Miltenyi Biotec UltraMicroscope Blaze imaging system. The upgrade is intended to increase the system's imaging speed by 60-fold to support 3D multispectral imaging of large tissue specimens. This award is not...

This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. for $24,990.50 on January 25, 2021, for a GentleMACS Octo Dissociator under COVID-19 funding. Performance is at Auburn, California. The order was placed under firm fixed price terms with an ultimate completion date of February 26, 2021. The solicitation posted January 20, 2021, with a due date of January 24, 2021.</p>